Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Azithromycin reduces airway inflammation induced by human rhinovirus in lung allograft recipients.

Ling KM, Hillas J, Lavender MA, Wrobel JP, Musk M, Stick SM, Kicic A.

Respirology. 2019 Apr 15. doi: 10.1111/resp.13550. [Epub ahead of print]

PMID:
30989728
2.

Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.

Chang A, Musk M, Lavender M, Wrobel J, Yaw MC, Lawrence S, Chirayath S, Boan P.

Transpl Infect Dis. 2019 Jun;21(3):e13085. doi: 10.1111/tid.13085. Epub 2019 Apr 16.

PMID:
30925010
3.

Cytomegalovirus viremia in lung transplantation during and after prophylaxis.

Chang A, Musk M, Lavender M, Wrobel J, Yaw MC, Lawrence S, Chirayath S, Boan P.

Transpl Infect Dis. 2019 Jun;21(3):e13069. doi: 10.1111/tid.13069. Epub 2019 Mar 22.

PMID:
30884067
4.

Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: Experience of the Australian Lung Transplant Collaborative.

Mackintosh JA, Munsif M, Ranzenbacher L, Thomson C, Musk M, Snell G, Glanville A, Chambers DC, Hopkins P.

J Heart Lung Transplant. 2019 May;38(5):553-559. doi: 10.1016/j.healun.2019.02.005. Epub 2019 Feb 12.

PMID:
30824289
5.

Influence of lung donor agonal and warm ischemic times on early mortality: Analyses from the ISHLT DCD Lung Transplant Registry.

Levvey B, Keshavjee S, Cypel M, Robinson A, Erasmus M, Glanville A, Hopkins P, Musk M, Hertz M, McCurry K, Van Raemdonck D, Snell G.

J Heart Lung Transplant. 2019 Jan;38(1):26-34. doi: 10.1016/j.healun.2018.08.006. Epub 2018 Aug 11.

PMID:
30297241
6.

Lung transplant: the Western Australian experience.

Dhillon S, McKinnon E, Wrobel J, Lavender M, Lawrence S, Gabbay E, Musk M.

Intern Med J. 2018 Nov;48(11):1337-1345. doi: 10.1111/imj.14001.

PMID:
29923278
7.

Beta-blocker under-use in COPD patients.

Lim KP, Loughrey S, Musk M, Lavender M, Wrobel JP.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 17;12:3041-3046. doi: 10.2147/COPD.S144333. eCollection 2017.

8.

Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study.

Chambers DC, Enever D, Lawrence S, Sturm MJ, Herrmann R, Yerkovich S, Musk M, Hopkins PM.

Stem Cells Transl Med. 2017 Apr;6(4):1152-1157. doi: 10.1002/sctm.16-0372. Epub 2017 Feb 1.

9.

Successful Single-Lung Transplant for Severe Lung Graft-Versus-Host Disease Two Years After Sibling Allograft for Acute Lymphoblastic Leukemia: A Case Report.

Irhimeh MR, Musk M, Cooney JP.

Transplant Proc. 2016 Nov;48(9):3227-3230. doi: 10.1016/j.transproceed.2016.07.003.

PMID:
27932188
10.

Penicillium marneffei infection in a lung transplant recipient.

Stathakis A, Lim KP, Boan P, Lavender M, Wrobel J, Musk M, Heath CH.

Transpl Infect Dis. 2015 Jun;17(3):429-34. doi: 10.1111/tid.12377. Epub 2015 May 19. Review.

PMID:
25809145
11.

Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin.

Banerjee B, Musk M, Sutanto EN, Yerkovich ST, Hopkins P, Knight DA, Lindsey-Temple S, Stick SM, Kicic A, Chambers DC.

PLoS One. 2012;7(12):e52309. doi: 10.1371/journal.pone.0052309. Epub 2012 Dec 21.

12.

Acute irreversible oxalate nephropathy in a lung transplant recipient treated successfully with a renal transplant.

Dheda S, Swaminathan R, Musk M, Sinniah R, Lawrence S, Irish A.

Nephrology (Carlton). 2012 Apr;17 Suppl 1:12-5. doi: 10.1111/j.1440-1797.2012.01585.x.

PMID:
22497648
13.

The airway epithelium is a direct source of matrix degrading enzymes in bronchiolitis obliterans syndrome.

Banerjee B, Ling KM, Sutanto EN, Musk M, Yerkovich ST, Hopkins PM, Stick SM, Kicic A, Chambers DC.

J Heart Lung Transplant. 2011 Oct;30(10):1175-85. doi: 10.1016/j.healun.2011.06.007. Epub 2011 Jul 23.

PMID:
21784664
14.

The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients.

Ng BJ, Glanville AR, Snell G, Musk M, Holmes M, Chambers DC, Hopkins PM.

Am J Transplant. 2011 Mar;11(3):568-74. doi: 10.1111/j.1600-6143.2010.03422.x. Epub 2011 Feb 7.

15.

Oil red O stain of alveolar macrophages is an effective screening test for gastroesophageal reflux disease in lung transplant recipients.

Hopkins PM, Kermeen F, Duhig E, Fletcher L, Gradwell J, Whitfield L, Godinez C, Musk M, Chambers D, Gotley D, McNeil K.

J Heart Lung Transplant. 2010 Aug;29(8):859-64. doi: 10.1016/j.healun.2010.03.015. Epub 2010 May 14.

PMID:
20466562
16.

Pulmonary hypertension in pregnancy: two cases and review of the literature.

Higton AM, Whale C, Musk M, Gabbay E.

Intern Med J. 2009 Nov;39(11):766-70. doi: 10.1111/j.1445-5994.2009.02051.x. Review.

PMID:
19912403
17.

Successful establishment of primary small airway cell cultures in human lung transplantation.

Banerjee B, Kicic A, Musk M, Sutanto EN, Stick SM, Chambers DC.

Respir Res. 2009 Oct 26;10:99. doi: 10.1186/1465-9921-10-99.

18.

Beware the pregnant woman with breathlessness.

Higton A, Whale C, Musk M, Gabbay E.

Thorax. 2009 Jul;64(7):580, 586. doi: 10.1136/thx.2008.105353. No abstract available.

PMID:
19561279
19.

Cells of epithelial lineage are present in blood, engraft the bronchial epithelium, and are increased in human lung transplantation.

May LA, Kicic A, Rigby P, Heel K, Pullen TL, Crook M, Charles A, Banerjee B, Ravine D, Saxena A, Musk M, Stick SM, Chambers DC.

J Heart Lung Transplant. 2009 Jun;28(6):550-7. doi: 10.1016/j.healun.2009.03.013.

PMID:
19481014
20.

Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition.

Hodge S, Holmes M, Banerjee B, Musk M, Kicic A, Waterer G, Reynolds PN, Hodge G, Chambers DC.

Am J Transplant. 2009 Apr;9(4):727-33. doi: 10.1111/j.1600-6143.2009.02558.x.

21.

Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis.

Phung S, Strange G, Chung LP, Leong J, Dalton B, Roddy J, Deague J, Playford D, Musk M, Gabbay E.

Intern Med J. 2009 Oct;39(10):682-91. doi: 10.1111/j.1445-5994.2008.01823.x. Epub 2008 Nov 3.

PMID:
19220532
22.

Pulmonary hypertension complicating sarcoidosis.

Rhodes B, Chambers D, Musk M, Gabbay E.

Intern Med J. 2008 Jul;38(7):613-4; author reply 614. doi: 10.1111/j.1445-5994.2008.01682.x. No abstract available.

PMID:
18715311
23.

Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus.

Hopkins P, McNeil K, Kermeen F, Musk M, McQueen E, Mackay I, Sloots T, Nissen M.

Am J Respir Crit Care Med. 2008 Oct 15;178(8):876-81. doi: 10.1164/rccm.200711-1657OC. Epub 2008 Jul 24.

PMID:
18658110
24.

Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management.

Musk M, Chambers D, Chin W, Murray R, Gabbay E.

J Heart Lung Transplant. 2006 Oct;25(10):1268-72. Review.

PMID:
17045941
25.

Laryngospasm induced by topical application of lignocaine.

Riley RH, Musk MT.

Anaesth Intensive Care. 2005 Apr;33(2):278. No abstract available.

26.

Respiratory symptoms and lung function in aborigines from tropical Western Australia.

Bremner PR, de Klerk NH, Ryan GF, James AL, Musk M, Murray C, Le Söuef PN, Young S, Spargo R, Musk AW.

Am J Respir Crit Care Med. 1998 Dec;158(6):1724-9.

PMID:
9847259
27.

Effects of amino acid dialysate on appetite in CAPD patients.

Musk M, Anderson H, Oreopoulos D, Leiter L, Bargman J, Pettit J, Jones M.

Adv Perit Dial. 1992;8:153-6.

PMID:
1361775

Supplemental Content

Support Center